Viatris Posts $3.75B in Third-Quarter Revenue
VTRS sits 95% above its 52-week low of $9.92.
Summary
Viatris reported third-quarter revenue of $3.75 billion, the first hard number from its Q3 release, alongside a 3Q loss per share of 28 cents and adjusted EPS of USD 0.71 versus an IBES estimate of USD 0.64. Adjusted EBITDA came in at $1.2 billion. The company raised its 2026 guidance midpoints across key metrics, narrowing its 2026 revenue view to $14.7 billion-$14.9 billion and raising its 2026 adjusted EPS view to $2.56-$2.63. The stock is trading near its 52-week high of $19.505, which raises the bar for the quarter. This lands while the $1.65 billion all-cash tender offer for Pacira at $36.50 a share runs to November 16, so the balance sheet and cash flow detail in the release matters as much as the top line.
At the time of this announcement, VTRS was trading at $19.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.1B. The 52-week trading range was $9.92 to $19.51. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.